The Current Status of Nuclear Medicine in Africa

We aimed to investigate the current status of nuclear medicine (NM) services across Africa, including identifying infrastructure gaps, radiopharmaceutical availability, systemic challenges, uneven growth trends, and efforts to improve access. <b>Methods:</b> Data on NM infrastructure, radiopharmaceutical availability, and challenges faced by NM professionals in the region were collected at regional International Atomic Energy Agency (IAEA) training courses, from IAEA databases, and by direct correspondence with NM professionals in the region between September 2024 and September 2025. <b>Results:</b> NM services are available in 29 countries. Seven countries have more than 1 SPECT or SPECT/CT camera per million inhabitants, and 12 countries offer PET/CT services, with no country in the region having more than 1 PET/CT camera per million inhabitants. There are 29 cyclotrons in 11 countries. There has been a 5.58% compound annual growth rate of SPECT or SPECT/CT and 32.8% growth (above global averages) in PET/CT cameras since 2022. <sup>99m</sup>Tc is available in all countries with NM services, and all, except Burkina Faso, have access to <sup>131</sup>I. Prostate-specific membrane antigen imaging is available in 9 countries, and somatostatin receptor type 2 imaging is available in 8 countries. Targeted radiopharmaceutical therapy services are limited to <sup>131</sup>I for benign or malignant thyroid disease in most countries. <sup>177</sup>Lu-therapies are restricted to 7 countries, and the availability of [<sup>131</sup>I]MIBG remains limited. Clinical trials with <sup>225</sup>Ac and <sup>161</sup>Tb are under way. Member states face similar challenges, including high costs of medical equipment and consumables, limited health care infrastructure, low government health care expenditures, weak economies, staff shortages, and limited educational opportunities. <b>Conclusion:</b> Despite challenges, there is clear momentum and NM growth in Africa. Although infrastructure, radiopharmaceutical access, and workforce gaps remain, data show progress. Sustained investment in facilities, training, and regulatory frameworks is essential to achieve equitable access to care. IAEA's regional anchor centers as part of the Rays of Hope initiative exemplifies strategic capacity building, collaboration, and knowledge sharing in the region.

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine
Published
2025-12-11
DOI
https://doi.org/10.2967/jnumed.125.271248
Citations
1
Primary Topic
Advances in Oncology and Radiotherapy
Type
article
Field-Weighted Citation Impact
1.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Current Status of Nuclear Medicine in Africa

Wasfy Omar, Kgomotso Mokoala, Enrique Estrada Lobato, Francesco Giammarile et al.
1 citations
Journal of Nuclear Medicine
Advances in Oncology and Radiotherapy
1.36
article

The Current Status of Nuclear Medicine in Africa

Wasfy Omar, Kgomotso Mokoala, Enrique Estrada Lobato, Francesco Giammarile, H. C. Nagaraj, Tamer M. Sakr, Aruna Korde, Amal Elrefaei, Olumayowa Kolade, Anita Brink, Janke Kleynhans, Peter Knoll, Anna Grigoryan, Diana Páez, Bethlehem W. Mekonnen, Bright A. Sangiwa, Francis Hashford
article en
1 citations

Abstract

We aimed to investigate the current status of nuclear medicine (NM) services across Africa, including identifying infrastructure gaps, radiopharmaceutical availability, systemic challenges, uneven growth trends, and efforts to improve access. <b>Methods:</b> Data on NM infrastructure, radiopharmaceutical availability, and challenges faced by NM professionals in the region were collected at regional International Atomic Energy Agency (IAEA) training courses, from IAEA databases, and by direct correspondence with NM professionals in the region between September 2024 and September 2025. <b>Results:</b> NM services are available in 29 countries. Seven countries have more than 1 SPECT or SPECT/CT camera per million inhabitants, and 12 countries offer PET/CT services, with no country in the region having more than 1 PET/CT camera per million inhabitants. There are 29 cyclotrons in 11 countries. There has been a 5.58% compound annual growth rate of SPECT or SPECT/CT and 32.8% growth (above global averages) in PET/CT cameras since 2022. <sup>99m</sup>Tc is available in all countries with NM services, and all, except Burkina Faso, have access to <sup>131</sup>I. Prostate-specific membrane antigen imaging is available in 9 countries, and somatostatin receptor type 2 imaging is available in 8 countries. Targeted radiopharmaceutical therapy services are limited to <sup>131</sup>I for benign or malignant thyroid disease in most countries. <sup>177</sup>Lu-therapies are restricted to 7 countries, and the availability of [<sup>131</sup>I]MIBG remains limited. Clinical trials with <sup>225</sup>Ac and <sup>161</sup>Tb are under way. Member states face similar challenges, including high costs of medical equipment and consumables, limited health care infrastructure, low government health care expenditures, weak economies, staff shortages, and limited educational opportunities. <b>Conclusion:</b> Despite challenges, there is clear momentum and NM growth in Africa. Although infrastructure, radiopharmaceutical access, and workforce gaps remain, data show progress. Sustained investment in facilities, training, and regulatory frameworks is essential to achieve equitable access to care. IAEA's regional anchor centers as part of the Rays of Hope initiative exemplifies strategic capacity building, collaboration, and knowledge sharing in the region.

Journal of Nuclear MedicineVol. 67(2)
International Atomic Energy Agency (AT), Cairo University (EG), Kenyatta University (KE), Stellenbosch University (ZA), University College Hospital, Ibadan (NG), Steve Biko Hospital (ZA), Kenyatta National Hospital (KE), Egyptian Atomic Energy Authority (EG), Ghana Atomic Energy Commission (GH), National Centre for Nuclear Energy, Science and Technology (MA), Ocean Road Cancer Institute (TZ), Addis Ababa University (ET), University of Pretoria (ZA), KU Leuven (BE)
Openalex Percentile: Top 14%
Advances in Oncology and Radiotherapy
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.